Ethics and regulation come into focus in the age of AI-powered clinical trials

Clinical Trials Arena November 1, 2024
Jenna Philpott

The role of emerging digital tools and AI were at the forefront of a panel discussion at the Outsourcing in Clinical Trials DACH 2024 conference.

As the role of technology and digital tools in clinical trials expands, industry leaders are grappling with how to balance innovation with ethical and regulatory safeguards.

Speaking at the Outsourcing in Clinical Trials (OCT) DACH 2024 conference in Zurich, Switzerland on 29-30 October, a panel weighed in on the challenges of integrating new digital tools – ranging from AI to wearables – in ways that are both effective and ethical.

“There is a lot of awareness from the regulators now that this has to be moved forward,” said Eva Herrmann-Keiner, senior clinical operations manager at...

Today's Sponsors

Today's Sponsor